标题
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases
作者
关键词
-
出版物
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Volume 188, Issue 3, Pages 271-278
出版商
American Thoracic Society
发表日期
2013-05-09
DOI
10.1164/rccm.201301-0021pp
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of Roflumilast in the COPD Frequent Exacerbator Phenotype
- (2013) Jadwiga A. Wedzicha et al. CHEST
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
- (2012) Jørgen Vestbo et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro
- (2012) J Milara et al. BRITISH JOURNAL OF PHARMACOLOGY
- Severe asthma: future treatments
- (2012) P. M. O'Byrne et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Selective PDE inhibitors as novel treatments for respiratory diseases
- (2012) Clive P Page et al. CURRENT OPINION IN PHARMACOLOGY
- Tetomilast: new promise for phosphodiesterase-4 inhibitors?
- (2012) Stephen J Bickston et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Phosphodiesterase inhibitors in inflammatory bowel disease
- (2012) Pooneh Salari et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of the Phosphodiesterase 4 Inhibitor Roflumilast on Glucose Metabolism in Patients with Treatment-Naive, Newly Diagnosed Type 2 Diabetes Mellitus
- (2012) E. F. M. Wouters et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial
- (2012) Kim Papp et al. LANCET
- Pathobiologic Mechanisms of Chronic Obstructive Pulmonary Disease
- (2012) Anthony Tam et al. MEDICAL CLINICS OF NORTH AMERICA
- Therapeutic Potential of ASP3258, a Selective Phosphodiesterase 4 Inhibitor, on Chronic Eosinophilic Airway Inflammation
- (2012) Miki Kobayashi et al. PHARMACOLOGY
- Disease Progression in MRL/lpr Lupus-Prone Mice Is Reduced by NCS 613, a Specific Cyclic Nucleotide Phosphodiesterase Type 4 (PDE4) Inhibitor
- (2012) Thérèse Keravis et al. PLoS One
- NCS 613, a potent and specific PDE4 inhibitor, displays anti-inflammatory effects on human lung tissues
- (2011) Issaka Yougbare et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease
- (2011) Klaus F. Rabe BRITISH JOURNAL OF PHARMACOLOGY
- PDE4: A Novel Target in the Treatment of Chronic Obstructive Pulmonary Disease
- (2011) J M Michalski et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Steroid Resistance in Severe Asthma: Current Mechanisms and Future Treatment
- (2011) A Durham et al. CURRENT PHARMACEUTICAL DESIGN
- Roflumilast with long-acting 2-agonists for COPD: influence of exacerbation history
- (2011) E. D. Bateman et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of repeated dose of erythromycin on the pharmacokinetics of roflumilast and roflumilast N-oxide
- (2011) G. Lahu et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Lack of pharmacokinetic and pharmacodynamic interactions of roflumilast with (R, S)-warfarin in healthy adult subjects
- (2011) N. McCracken et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats
- (2010) Chiharu Sadakane et al. Clinical and Experimental Nephrology
- Population Pharmacokinetic Modelling of Roflumilast and Roflumilast N-Oxide by Total Phosphodiesterase-4 Inhibitory Activity and Development of a Population Pharmacodynamic-Adverse Event Model
- (2010) Gezim Lahu et al. CLINICAL PHARMACOKINETICS
- The flavonoid dioclein reduces the production of pro-inflammatory mediators in vitro by inhibiting PDE4 activity and scavenging reactive oxygen species
- (2010) Rodrigo Guabiraba et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pharmacology of a potent and selective inhibitor of PDE4 for inhaled administration
- (2010) Richard W. Chapman et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effect of Steady-State Enoxacin on Single-Dose Pharmacokinetics of Roflumilast and Roflumilast N-Oxide
- (2010) Gezim Lahu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- No Dose Adjustment on Coadministration of the PDE4 Inhibitor Roflumilast With a Weak CYP3A, CYP1A2, and CYP2C19 Inhibitor: An Investigation Using Cimetidine
- (2010) Gabriele M. Böhmer et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The preclinical pharmacology of roflumilast – A selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease
- (2010) Armin Hatzelmann et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Quinolines as a novel structural class of potent and selective PDE4 inhibitors. Optimisation for inhaled administration
- (2009) Michael D. Woodrow et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury
- (2009) J Cortijo et al. BRITISH JOURNAL OF PHARMACOLOGY
- A controlled trial of 6-weeks' treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD
- (2009) J. Vestbo et al. EUROPEAN RESPIRATORY JOURNAL
- Relationship between phosphodiesterase type 4 inhibition and anti-inflammatory activity of CI-1044 in rat airways
- (2009) Marie-Pierre Pruniaux et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Zl-n-91, a selective phosphodiesterase 4 inhibitor, suppresses inflammatory response in a COPD-like rat model
- (2009) Ya-juan Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Targeted Oral, Once-Daily Phosphodiesterase 4 Inhibitor Roflumilast and the Leukotriene Receptor Antagonist Montelukast Do Not Exhibit Significant Pharmacokinetic Interactions
- (2009) Gabriele M. Böhmer et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
- (2009) Leonardo M Fabbri et al. LANCET
- Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
- (2009) Peter MA Calverley et al. LANCET
- Immunologic Aspects of Chronic Obstructive Pulmonary Disease
- (2009) Manuel G. Cosio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacology of a Novel, Orally Active PDE4 Inhibitor
- (2009) Sunanda G. Dastidar et al. PHARMACOLOGY
- Rolipram attenuates bleomycin A5-induced pulmonary fibrosis in rats
- (2009) Jin Bing PAN et al. RESPIROLOGY
- Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
- (2009) Miles D. Houslay TRENDS IN BIOCHEMICAL SCIENCES
- Effects of KF19514, a Phosphodiesterase 4 and 1 Inhibitor, on Bronchial Inflammation and Remodeling in a Murine Model of Chronic Asthma
- (2009) Toshiyuki Kita et al. ALLERGOLOGY INTERNATIONAL
- The Efficacy and Safety of Cilomilast in COPD
- (2008) Stephen Rennard et al. DRUGS
- Effect of orally administered KF66490, a phosphodiesterase 4 inhibitor, on dermatitis in mouse models
- (2008) Daisuke Harada et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Effect of Single and Repeated Doses of Ketoconazole on the Pharmacokinetics of Roflumilast and Roflumilast N-Oxide
- (2008) Gezim Lahu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed mice
- (2008) Piero A Martorana et al. BMC Pulmonary Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started